“…26 Covid-19 vaccination may protect children under 5 at high risk of severe disease. 27 But the case for mass vaccination of healthy under 5s seems less compelling, 15 particularly in developed countries where risk of mortality from covid-19 in this age group is so low. 28 However, the balance of benefits and risks may change as new variants emerge.…”
Section: Opportunity Costsmentioning
confidence: 99%
“…Covid-19 vaccination could reduce incidence of severe disease among under 5s considered at highest risk15 and may protect them against the rarer multisystem inflammatory syndrome, as observed in children aged over 12 years 18. This complication has also been reported after covid-19 vaccination in older children, but at lower rates than occur following natural infection 19.…”
mentioning
confidence: 98%
“…Should children under 5 years be vaccinated against covid-19? In high income settings such as the UK the benefit of vaccination for healthy children under 5 years is likely to be even more marginal than it is for older children 15. Most under 5s will have been exposed to SARS-CoV-2 already.…”
mentioning
confidence: 99%
“…In high income settings such as the UK the benefit of vaccination for healthy children under 5 years is likely to be even more marginal than it is for older children. 15 Most under 5s will have been exposed to SARS-CoV-2 already. For example, 75% of children aged 0-11 years in the US had antibodies to SARS-CoV-2 in February 2022, 16 and this figure has probably increased.…”
mentioning
confidence: 99%
“…Uncertainty remains about how much additional protection the vaccine offers against covid-19 or how long antibodies last compared with antibodies developed through natural immunity. 17 Covid-19 vaccination could reduce incidence of severe disease among under 5s considered at highest risk 15 and may protect them against the rarer multisystem inflammatory syndrome, as observed in children aged over 12 years. 18 This complication has also been reported after covid-19 vaccination in older children, but at lower rates than occur following natural infection.…”
“…26 Covid-19 vaccination may protect children under 5 at high risk of severe disease. 27 But the case for mass vaccination of healthy under 5s seems less compelling, 15 particularly in developed countries where risk of mortality from covid-19 in this age group is so low. 28 However, the balance of benefits and risks may change as new variants emerge.…”
Section: Opportunity Costsmentioning
confidence: 99%
“…Covid-19 vaccination could reduce incidence of severe disease among under 5s considered at highest risk15 and may protect them against the rarer multisystem inflammatory syndrome, as observed in children aged over 12 years 18. This complication has also been reported after covid-19 vaccination in older children, but at lower rates than occur following natural infection 19.…”
mentioning
confidence: 98%
“…Should children under 5 years be vaccinated against covid-19? In high income settings such as the UK the benefit of vaccination for healthy children under 5 years is likely to be even more marginal than it is for older children 15. Most under 5s will have been exposed to SARS-CoV-2 already.…”
mentioning
confidence: 99%
“…In high income settings such as the UK the benefit of vaccination for healthy children under 5 years is likely to be even more marginal than it is for older children. 15 Most under 5s will have been exposed to SARS-CoV-2 already. For example, 75% of children aged 0-11 years in the US had antibodies to SARS-CoV-2 in February 2022, 16 and this figure has probably increased.…”
mentioning
confidence: 99%
“…Uncertainty remains about how much additional protection the vaccine offers against covid-19 or how long antibodies last compared with antibodies developed through natural immunity. 17 Covid-19 vaccination could reduce incidence of severe disease among under 5s considered at highest risk 15 and may protect them against the rarer multisystem inflammatory syndrome, as observed in children aged over 12 years. 18 This complication has also been reported after covid-19 vaccination in older children, but at lower rates than occur following natural infection.…”
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.